Peter Thiel’s Thiel Bio and Jeff Bezos’ Bezos Expeditions are among the investors backing health-care company HistoSonics Inc. at a $3 billion valuation — betting that its technology that can help treat tumors using sound waves.
The startup, which currently focuses on liver tumors, will use the fresh $250 million investment from the deal to expand the applications of its ultrasound therapy devices to target growths in the breast, prostate, pancreas and other areas. HistoSonics is also accelerating its work targeting brain cancer.
First Appeared on
Source link
